Add Presentation to Slide Tray Presentation:
Progestogens for Prevention of Preterm Birth
Authors: Kjersti Aagaard, MD, PhD
Clinical Questions Addressed by the Comparative Effectiveness Review (2 of 2)
Other clinical questions address by the comparative effectiveness review were:
- How do effectiveness, adverse effects, and safety of progestogen treatment differ based on the formulation, dose, frequency of administration and gestational age at initiation or discontinuation of progestogen therapy?
- How do effectiveness, acceptability, adherence, adverse effects, and safety of progestogen treatment differ based on the cointerventions used to prevent preterm birth and its consequences?
- Likis FE, Andrews JC, Woodworth AL, et al. Effectiveness of Progestogens for Prevention of Preterm Birth. Comparative Effectiveness Review No. 74 (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2007-10065-I). Rockville, MD: Agency for Healthcare Research and Quality; September 2012. AHRQ Publication No. 12-EHC105-EF. Available at www.effectivehealthcare.ahrq.gov/pretermbirth.cfm.
Your slide tray is being processed.